Product Information

MIRTAZAPINE 30 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0897 per EA under NDC 00378353093. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jun 19, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIRTAZAPINE 30 MG TABLET

Mirtazapine
$0.0897per EA

Strength

30 mg/1

NDC

00378353093

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MIRTAZAPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA076122

FDA Approved

6/19/2003

TE Code

AB

On Market Since

6/20/2003

Price Statistics

The NADAC for MIRTAZAPINE 30 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0897 per EA
All-time high$0.2592 (Aug 13, 2014)
All-time low$0.0716 (Nov 20, 2024)
52-week high$0.0908
52-week low$0.0858
Median price$0.1101
Average price$0.1234
Largest weekly change+24.5% (Dec 23, 2015)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.4%

3M

+3.0%

6M

-1.2%

1Y

+0.2%

3Y

+9.6%

5Y

-12.0%

All

-36.9%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIRTAZAPINE 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0897 per EA (NDC 00378353093), effective Nov 11, 2026.

How has the price of MIRTAZAPINE 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG TABLET has declined 36.9%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG TABLET?

Since Nov 28, 2013, the NADAC for MIRTAZAPINE 30 MG TABLET has ranged from a low of $0.0716 (Nov 20, 2024) to a high of $0.2592 (Aug 13, 2014), with a median of $0.1101 per EA.

Are there cheaper alternatives to MIRTAZAPINE 30 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 19% below MIRTAZAPINE 30 MG TABLET.

Who manufactures MIRTAZAPINE 30 MG TABLET?

MIRTAZAPINE 30 MG TABLET (NDC 00378353093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.